- Bite Science
- Posts
- Teleportation Of Logical Qubit, Promising Med for Tourettes, SpaceX Crew-8 Concludes Mission
Teleportation Of Logical Qubit, Promising Med for Tourettes, SpaceX Crew-8 Concludes Mission

🤖 Tech & Computer Science
The authors propose a novel weakly supervised video anomaly detection method that integrates multimodal and multiscale features to address challenges such as video blur and occlusion. Their approach includes an Attention De-redundancy module to filter out irrelevant information, a Multi-scale Feature Learning module for capturing temporal dependencies, and an Adaptive Feature Fusion module for effective feature combination. Experimental results demonstrate that this method outperforms existing approaches, achieving 97.00% AUC on ShanghaiTech and 85.31% AUC on UCF-Crime.
The authors introduce One-Shot Style Adaptation (OSSA), an unsupervised domain adaptation method for object detection that uses a single unlabeled target image to derive diverse styles. By applying these styles to a labeled source dataset through Adaptive Instance Normalization (AdaIN), OSSA outperforms existing one-shot adaptation methods and even some that use thousands of unlabeled images. Its efficiency and ease of integration make it suitable for applications with limited data availability.
⚛️ Physics and Chemistry
Researchers at the University of Bonn and University of Kaiserslautern-Landau found that an optical quantum gas transitions smoothly from 2D to 1D, rather than abruptly condensing. By modifying a 2D photon gas in an optical microcavity, they created a 1D structure and observed significant thermal fluctuations in 1D, which contrasts with negligible effects in 2D, supporting theoretical predictions about this exotic state of matter.
Quantinuum researchers achieved the first teleportation of a logical qubit using fault-tolerant methods, as detailed in Science. By utilizing their H2 trapped-ion quantum processor, they employed two methods: a transversal approach for faster teleportation by manipulating multiple qubits simultaneously, and lattice surgery for improved compatibility by adjusting qubit boundaries. This advancement addresses the error-prone nature of quantum computers.
🧬 Biology & Medicine
Ecopipam, a dopamine-1 receptor antagonist, reduces tic severity in children and adolescents with Tourette syndrome without worsening comorbid conditions like ADHD and depression. In a 12-week phase 2b trial, it lowered tic scores by 30% compared to placebo, with no adverse effects on nonmotor symptoms, according to investigator Donald Gilbert at the MDS 2024 Congress.
Researchers have developed a three-dimensional photoacoustic tomography (PAT) scanner for rapid vascular imaging, published in Nature Biomedical Engineering. PAT effectively visualizes microvasculature to sub-centimeter depths by generating ultrasound waves through tissue absorption from a pulsed laser, overcoming limitations of both optical and ultrasound imaging. However, challenges persist with conventional piezoelectric detectors, which lack sensitivity for small elements.
🔭 Space & Astronomy
On October 2, an annular solar eclipse will occur, visible from the Pacific Ocean, southern Chile, and Argentina. The best viewing time is from 3:03 to 3:09 p.m. EDT, especially from Easter Island, where the "ring of fire" will be visible for up to 6 minutes. About 175,000 people live in the path of annularity, while others will see a partial eclipse.
NASA astronauts Michael Barratt, Matthew Dominick, and Jeanette Epps, along with Roscosmos cosmonaut Alexander Grebenkin, are returning to Earth after their SpaceX Crew-8 mission aboard the International Space Station. During their mission, they conducted scientific experiments, including the Genomic Enumeration of Antibiotic Resistance in Space, led by Epps, which aimed to identify antibiotic-resistant microorganisms and their adaptations to space. This research could help protect astronauts and improve safety in healthcare facilities on Earth.
Thanks For Reading!
Please move this email to your Primary Inbox (if it is not already there) to make sure you don’t miss any of the exciting news and updates!
Reply directly to this email with any questions, comments or suggestions. 🚀